This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

High-risk compound

Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-FOR-NOW — current cost / risk / redundancy puts it below the line.

Browse

Evekeo

Emerging

SKIP-FOR-NOW for users in this archetype — same family rationale as Adderall, refer to that file as parent analysis.

Aliases (5)

Racemic amphetamine sulfate · dl-amphetamine sulfate · Benzedrine (historical) · Evekeo ODT (orally disintegrating) · AMPH-IR-50/50

TYPICAL DOSE

5-10mg

Daily

ROUTE

Oral (tablet)

Oral

CYCLE

Same harm-reduction patterns as Adderall (5-on-…

As prescribed

STORAGE

Room temp; original container

Room temp

Overview

What is Evekeo?

Evekeo is a brand of racemic amphetamine sulfate (50:50 d/l-amphetamine) in immediate-release tablets, FDA-approved for ADHD, narcolepsy, and exogenous obesity. Same active ingredient as the original Benzedrine.

Key Benefits

Treats ADHD with a more anxiolytic and 'softer' profile than pure dextroamphetamine due to higher l-isomer content. Useful for narcolepsy and treatment-resistant ADHD when Adderall is unavailable.

Mechanism of Action

Racemic amphetamine reverses DAT and NET to release dopamine and norepinephrine; inhibits VMAT2 and weakly inhibits MAO. The l-isomer contributes more to peripheral and noradrenergic effects than d-isomer.

Pharmacokinetics

PeakHalf-life

Approximate curve — visual aid only, not data-precise PK

▸Brand options1 known

Racemic amphetamine sulfate

StatusSchedule II (US DEA) | Schedule II (Canada CDSA) | Class B (UK) | Schedule 8 (Australia) | WADA-banned in-competition (S6 stimulant)

Peptide Interactions

l-theanine 200mg co-administered:

Synergistic

Same as Adderall — smooths anxiety, reduces jaw tension. May be *more useful* with Evekeo than Adderall given higher peripheral NE load.

magnesium glycinate / threonate:

Synergistic

Cardiovascular tolerance, sleep on dose days. Already in the user's V stack.

citicoline:

Synergistic

Cholinergic support. Already in the user's V stack.

Quality Indicators

✓

Pharmacy-dispensed, intact packaging

Prescription tablets in original sealed packaging from a licensed pharmacy.

Generic vs branded

Generics are usually fine but bioavailability can vary slightly; track if you switch.

✗

Unbranded blister or counterfeit risk

Counterfeit pharmaceuticals are a known issue; verify pharmacy and lot if buying internationally.

What to Expect

Day 1
PK-driven acute peak per administration. Verify dose tolerated.
Week 1
Steady-state reached for most daily-dosed pharma.
Week 2-4
Therapeutic effect established; titration window if needed.
Long-term
Periodic monitoring per drug class (labs, BP, ECG as applicable).

Side Effects & Safety 5

Side Effects

1Same as Adderall, with slightly more peripheral cardiovascular signal (HR, BP, palpitations) per mg of CNS effect due to higher l-amphetamine fraction.
2Bruxism / jaw clenching may be slightly more pronounced.
3Appetite suppression — class effect, unchanged.
4Same as Adderall.
5Peripheral vasoconstriction effects (cold extremities, Raynaud's-like) may be slightly more common.

When to Stop

Cardiomyopathy / heart failure with chronic use — same class concern as Adderall, theoretically slightly elevated risk per mg of CNS-active drug due to higher peripheral NE load.
All other class risks (sudden cardiac death, stroke/MI, psychosis, mania switch, serotonin syndrome with MAOIs, SJS, vasculopathy, stimulant use disorder, withdrawal syndrome) — see Adderall.
Same as Adderall — first 2 weeks for cardiovascular adjustment, months 1-6 for tolerance/dose-creep, year 1+ for cardiac structural changes.